|
EC Cracks Down on ‘Pay-for-Delay,’ Charging Slew of Generic Makers
The European Commission (EC) has accused two brand drugmakers of violating antitrust rules by engaging in “pay-for-delay” agreements with a slew of generic companies, sending both the brand and generic companies Statement of Objections notices.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives